PATENT CLAIM ANALYSIS

Application Number: 15906721
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["424", "094600"]

Abstract:
The present invention provides isolated dimeric  Streptococcus -specific phage lysins having two  Streptococcus -specific phage lysin monomers covalently linked to each other, and having killing activity against one or more  Streptococcus  bacteria. Also provided for are pharmaceutical compositions of dimeric lysins and their use in therapeutic treatment or alleviation of infections or bacterial colonizations. The dimeric lysins may also be used to decontaminate porous and non-porous surfaces or devices.

Claim (Index 9):
The lysin of  claim 8 , wherein the catalytic domain of a first  Streptococcus -specific phage lysin is mutant Cpl-1 (SEQ ID NO:3), mutant Pal SEQ ID NO:6 (SEQ ID NO:5) or another Streptococcal phage lysin.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 1.35185
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14349736', '15007445', '14685696', '15492128', '14399588']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7676721729093289
- 35 USC 102 Novelty (BERT): 0.6260421389926668
- Combined Prediction Score: 0.7535091695176628
- Mean Citation Score: 481.589922
- Max Citation Score: 627.3702
- Similarity Product: 498.6142674542427

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test